Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atypical pathogen pneumonia

D Lieberman1, D Lieberman

  • 1Pulmonary Unit, Soroka Medical Center, Beer-Sheva, Israel.

Current Opinion in Pulmonary Medicine
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Atypical pathogens like Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella cause community-acquired pneumonia. New macrolide antibiotics may shorten treatment duration for these infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An injection-lite approach to ovarian stimulation in poor responder patients using corifollitropin alfa and nasal GnRH agonist.

Journal of assisted reproduction and genetics·2026
Same author

Women's interest, knowledge, and attitudes relating to anti-Mullerian hormone testing: a randomized controlled trial.

Human reproduction (Oxford, England)·2024
Same author

'Your hopes can run away with your realistic expectations': a qualitative study of women and men's decision-making when undergoing multiple cycles of IVF.

Human reproduction open·2021
Same author

Editorial: smoking status and 5-year survival in patients with colorectal cancer.

Alimentary pharmacology & therapeutics·2017
Same author

Letters.

The Physician and sportsmedicine·2016
Same author

Letters.

The Physician and sportsmedicine·2016
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Atypical pathogens, including Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella species, are increasingly recognized causes of pneumonia.
  • Advancements in diagnostic techniques have led to a rise in identified cases of atypical pathogen-associated community-acquired pneumonia.
  • The clinical presentation of atypical pneumonia is often indistinguishable from other forms of community-acquired pneumonia.

Purpose of the Study:

  • To review the significance of atypical pathogens in community-acquired pneumonia.
  • To discuss the diagnostic challenges and spectrum of severity associated with these infections.
  • To explore current and emerging therapeutic options for atypical pneumonia.

Main Methods:

  • Review of current literature on atypical pathogens and community-acquired pneumonia.

Related Experiment Videos

  • Analysis of diagnostic approaches and clinical manifestations.
  • Evaluation of antibiotic treatment strategies, including macrolides.

    • Main Results:

    • Atypical pathogen pneumonia ranges from mild illness to severe respiratory distress requiring mechanical ventilation.
    • Clinical, radiological, and laboratory findings are not sufficient for definitive etiological diagnosis.
    • Newer macrolide antibiotics offer potential for shortened treatment durations compared to standard regimens.

    Conclusions:

    • Accurate diagnosis of atypical pneumonia relies on specific microbiological and serological tests.
    • Prompt identification and appropriate antibiotic selection are crucial for managing atypical pneumonia.
    • The introduction of novel macrolides provides an effective option for treating atypical pathogens, potentially reducing treatment time.